February 4th 2026
Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.
Robert W. Dubois, MD, PhD, Describes the Initial Expectations of Accountable Care Organizations
April 4th 2013Robert W. Dubois, MD, PhD, the chief science officer of the National Pharmaceutical Council discusses the initial expectations of implementing accountable care organizations (ACOs) and how those expectations have evolved over time.
Read More